373 assets in Non-Hodgkin Lymphoma

Palifermin

Peg-Rhg-Csf

Tocilizumab

Venetoclax

Clofarabine

Golcadomide

Tucidinostat

Ciprofloxacin

Copanlisib

Abemaciclib

Blinatumomab

Ceftazidime

Dasatinib

Ipilimumab

Isatuximab

Mesna

Regorafenib

Vitamin D

Vorinostat

Zanubrutinib

Abexinostat

Amoxicillin

Atezolizumab

Daratumumab

dzd8586

Epcoritamab

Nadravaleucel

Ppsv23

Prevenar 13

Prevnar 20

Ruxolitinib

Tafasitamab

Vemurafenib

Vismodegib

Zoledronate

Autologous Cd4+ And Cd8+ T Cells, Enriched From Peripheral Blood Mononuclear Cells (Pbmcs) Transduced With A Nonreplicative Self-Inactivating (Sin) Lentiviral Vector Encoding A Chimeric Antigen Receptor (Car) Consisting Of The Human Cd19-Specific Scfv, An Lgg4 Hinge Region, Cd28 Transmembrane Domain, Cd137 (4-1Bb) Co-Stimulatory Domain And Cd3 Zeta Signalling Domain, Under The Control Of A Hybrid Elongation Factor 1 Alpha (Ef1.Alpha.) And Human T Cell Leukemia Virus Type 1(Htlv-1) Regulatory Element Promoter And Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (Wpre). The Vector Genome Also Encodes A Truncated Human Epidermal Growth Factor Receptor (Egfrt) That Is Co-Expressed With The Car And Cleaved From It By The T2A Self-Cleaving Peptide. The Vector Genome Also Contains A Splice Donor, A Fragment Of Gag, A Rev Response Element (Rre), A Mutated Central Polypurine Tract (Cppt), And A Splice Acceptor

Belinostat

Palbociclib

Panobinostat

Siltuximab

Trametinib

2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-

Azacitidine

Clavulanic Acid

Dabrafenib

Human Immunoglobulins

PI3K/MTOR INHIBITOR LY3023414

Sulfamethoxazole

Talikabtagene Autoleucel

Thalidomide